Wendi Xuzhang

机构：Sun Yat-sen University, Shanghai Chest Hospital, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

发表论文 11 篇 · 总被引 90 次 · h-index 5

代表论文

• Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis (2023 · International Journal of Biological Sciences · 被引 38)
• Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model (2023 · Pharmacological Research · 被引 16)
• Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC (2023 · Therapeutic Advances in Medical Oncology · 被引 16)
• The global burden of mesothelioma and its association with asbestos bans, 1990–2021: a population-based study (2025 · Lung Cancer · 被引 7)
• Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002) (2026 · Journal of Clinical Oncology · 被引 5)
• BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 4)